Literature DB >> 5333593

Experimental inclusion conjunctivitis in man. II. Partial resistance to reinfection.

C Dawson, E Jawetz, L Hanna, L Rose, T R Wood, P Thygeson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5333593     DOI： 10.1093/oxfordjournals.aje.a120654

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN： 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  5 in total

1.  Development of chronic conjunctivitis with scarring and pannus, resembling trachoma, in guinea-pigs.

Authors:  M A Monnickendam; S Darougar; J D Treharne; A M Tilbury
Journal:  Br J Ophthalmol       Date:  1980-04       Impact factor: 4.638

Review 2.  Towards a safe and effective chlamydial vaccine: lessons from the eye.

Authors:  David C W Mabey; Victor Hu; Robin L Bailey; Matthew J Burton; Martin J Holland
Journal:  Vaccine       Date:  2014-03-20       Impact factor: 3.641

3.  A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C/C-related complex serovars.

Authors:  Anja Weinreich Olsen; Ida Rosenkrands; Martin J Holland; Peter Andersen; Frank Follmann
Journal:  NPJ Vaccines       Date:  2021-04-19       Impact factor: 9.399

Review 4.  Trachoma: protective and pathogenic ocular immune responses to Chlamydia trachomatis.

Authors:  Victor H Hu; Martin J Holland; Matthew J Burton
Journal:  PLoS Negl Trop Dis       Date:  2013-02-14

5.  Inverse relationship between microRNA-155 and -184 expression with increasing conjunctival inflammation during ocular Chlamydia trachomatis infection.

Authors:  Tamsyn Derrick; Anna R Last; Sarah E Burr; Chrissy H Roberts; Meno Nabicassa; Eunice Cassama; Robin L Bailey; David C W Mabey; Matthew J Burton; Martin J Holland
Journal:  BMC Infect Dis       Date:  2016-02-03       Impact factor: 3.090
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.